Example: Heart Attack

Search clinical trials for: Alprazolam

Total 77 results

NCT04802746

Recruiting

A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma

Conditions: Healthy Study Participants, Participants With Mild Asthma
NCT04857307

Recruiting

A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy

Conditions: Epilepsy
NCT04782388

Completed

Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants

Conditions: Healthy Study Participants
NCT03948243

Active, not recruiting

Licorice Botanical Dietary Supplements - Metabolism and Safety in Women

Conditions: Food-drug Interaction
NCT03327506

Recruiting

Preoperative Hypnosis Versus Premedication in Gynecological Surgery

Conditions: Gynecologic Disease, Anxiety Disease
NCT03478982

Completed

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

Conditions: Epilepsy
NCT01256151

Completed

Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet

Conditions: Anxiety Disorder
NCT00860119

Completed

Bioequivalence of Alprazolam Sublingual vs Oral Tablets

Conditions: Healthy
NCT00810316

Completed

Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population

Conditions: Pharmacokinetics
NCT01322867

Completed

A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets

Conditions: Healthy
NCT00635531

Terminated

A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

Conditions: Panic Disorder
NCT00635076

Terminated

A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder

Conditions: Panic Disorder
NCT00634790

Terminated

A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks

Conditions: Panic Disorder
NCT01027689

Withdrawn

Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation

Conditions: Healthy
NCT00877955

Withdrawn

Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation

Conditions: Healthy
NCT01285505

Withdrawn

Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation

Conditions: Healthy
NCT01046162

Withdrawn

A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions

Conditions: Healthy
NCT00245609

Completed

Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure

Conditions: Dental Anxiety
NCT04715269

Recruiting

Role of Alprazolam in the Management of Acute Coronary Syndrome

Conditions: Acute Coronary Syndrome, Myocardial Infarction, ST Elevation Myocardial Infarction, Heart Diseases, Anxiety
NCT04658732

Recruiting

A Comparative Study of Oral Gabapentin, Oral Alprazolam and Intravenous Dexmedetomidine on Perioperative Anxiety and Pain During Posterior Segment Eye Surgery Under Peribulbar Block : a Randomized, Double-blind Study.

Conditions: Sedation for Patients Undergoing Peribulbar Block
NCT04592536

Recruiting

A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects

Conditions: Panic Disorder
NCT03635437

Recruiting

Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes

Conditions: Type 1 Diabetes Mellitus
NCT03702803

Recruiting

Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety.

Conditions: Generalized Anxiety Disorder
NCT03297944

Completed

Sedative-Anxiolytic Effects on Simulated Driving Performance

Conditions: Psychomotor Impairment
NCT03012334

Completed

The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants

Conditions: Migraine